Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

Clinical trial NCT06782685 · RECRUITING

Trial details

NCT number: NCT06782685
Sponsor: Dai, Guanghai
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Pancreatic Cancer (Part 1)

Start date: 2024-06-23
Primary completion: 2026-07-01
Enrollment: 138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.